Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project).
Fort-Casamartina E, Pernas S, Otero S, Mate P, Gonzalo N, Narváez S, Rigo-Bonnin R, Padró-Miquel A, Teulé À, Garcia Del Muro X, Peiró I, Arribas L, Esteve A, Gonzalez A, Rey M, Clopés A, Fontanals S, Muñoz C. Fort-Casamartina E, et al. Among authors: esteve a. J Clin Med. 2024 Dec 30;14(1):145. doi: 10.3390/jcm14010145. J Clin Med. 2024. PMID: 39797229 Free PMC article.
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
Plaja A, Teruel I, Ochoa-de-Olza M, Cucurull M, Arroyo ÁJ, Pardo B, Ortiz I, Gil-Martin M, Piulats JM, Pla H, Fina C, Carbó A, Barretina-Ginesta MP, Martínez-Román S, Carballas E, González A, Esteve A, Romeo M. Plaja A, et al. Among authors: esteve a. Int J Mol Sci. 2023 Jul 13;24(14):11420. doi: 10.3390/ijms241411420. Int J Mol Sci. 2023. PMID: 37511180 Free PMC article.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A, Domenech M, Buisan O, Lopez H, González A, Etxaniz O, Matas M, Elias X, Gomez M, Figols M, Horneros J, Pardo JC, Notario L, Ruiz de Porras V, Perez I, Areal J, Esteve A. Font A, et al. Among authors: esteve a. World J Urol. 2022 Nov;40(11):2627-2634. doi: 10.1007/s00345-022-04147-4. Epub 2022 Sep 15. World J Urol. 2022. PMID: 36107212
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M, Calvet G, Pérez-Montero H, Esteve A, Bujalance MV, Navarro-Martín A, Fernández MDA, González FF, Borras SM, Borbalas AL, Fernandez MN, Garau MM, Calduch AL, Edo FG. Stefanovic M, et al. Among authors: esteve a. Clin Transl Oncol. 2023 Jan;25(1):199-206. doi: 10.1007/s12094-022-02923-7. Epub 2022 Sep 6. Clin Transl Oncol. 2023. PMID: 36068449
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
Carrato C, Alameda F, Esteve-Codina A, Pineda E, Arpí O, Martinez-García M, Mallo M, Gut M, Lopez-Martos R, Barco SD, Ribalta T, Capellades J, Puig J, Gallego O, Mesia C, Muñoz-Marmol AM, Archilla I, Arumí M, Blanc JM, Bellosillo B, Menendez S, Esteve A, Bagué S, Hernandez A, Craven-Bartle J, Fuentes R, Vidal N, Aldecoa I, Iglesia N, Balana C. Carrato C, et al. Among authors: esteve a, esteve codina a. Clin Cancer Res. 2020 Dec 15;26(24):6600-6609. doi: 10.1158/1078-0432.CCR-20-2171. Epub 2020 Sep 30. Clin Cancer Res. 2020. PMID: 32998960
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí O, Martinez-García M, Mallo M, Gut M, Dabad M, Tortosa A, Del Barco S, Capellades J, Puig J, Gallego O, Pujol T, Oleaga L, Gil-Gil M, de Quintana-Schmidt C, Valduvieco I, Martinez-Cardús A, Bellosillo B, Muñoz-Marmol AM, Esteve A, Domenech M, Camins A, Craven-Bartle J, Villa S, Marruecos J, Domenech S, de la Iglesia N, Balana C. Esteve-Codina A, et al. Among authors: esteve a. Clin Cancer Res. 2021 Jan 15;27(2):645-655. doi: 10.1158/1078-0432.CCR-20-2141. Epub 2020 Oct 26. Clin Cancer Res. 2021. PMID: 33106291
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab.
Panciroli C, Lucente G, Vidal L, Carcereny E, Quiroga V, Pardo JC, Romeo M, Estival A, Manzano JL, Pardo B, Velarde JM, Esteve AM, Lopez D, Mañes A, Tuset V, Villà S, Quintero CB. Panciroli C, et al. Among authors: esteve am. Clin Transl Oncol. 2020 Mar;22(3):411-419. doi: 10.1007/s12094-019-02143-6. Epub 2019 May 29. Clin Transl Oncol. 2020. PMID: 31144211
Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.
González V, Martró E, Folch C, Esteve A, Matas L, Montoliu A, Grífols JR, Bolao F, Tural C, Muga R, Parry JV, Ausina V, Casabona J. González V, et al. Among authors: esteve a. Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):121-6. doi: 10.1007/s10096-007-0408-z. Epub 2007 Nov 20. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18027006
249 results